{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T23:27:09.93403+00:00","published_at":"2026-10-16T13:52:54.339891+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:12fnahkuki486","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-09","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:chris-jewell-ph-d","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:d9c326fbc68efba709f97bcbe5eaa467259e9a0a435163bfaca28386c1f3ed51"],"summary":"Chris Jewell, Ph.D. executive of Cartesian Therapeutics, Inc., effective 2026-03-09.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14mzyuui65rca","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-09","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:metin-kurtoglu-m-d-ph-d","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:119a80c5445b9498e6e4a1eef46f92b9a98732202336688ad2930bff031afba8"],"summary":"Metin Kurtoglu, M.D., Ph.D. executive of Cartesian Therapeutics, Inc., effective 2026-03-09.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1yb5tgbcf5gzp","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:kemal-malik-m-b-b-s","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Kemal Malik, M.B.B.S. seat on Cartesian Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:w21qlr1yjldh","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:michael-singer-m-d-ph-d","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Michael Singer, M.D., Ph.D. seat on Cartesian Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jqjnio1nm98nc","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:murat-kalayoglu-m-d-ph-d","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Murat Kalayoglu, M.D., Ph.D. seat on Cartesian Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1qur7161dezzki","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:nishan-de-silva-m-d-m-b-a","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Nishan de Silva, M.D., M.B.A. seat on Cartesian Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:4j7c0z1mnz2nl","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:carrie-s-cox","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Carrie S. Cox seat on Cartesian Therapeutics, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16z230l9ayd5x","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:committee:cartesian-therapeutics-inc:audit-compensation-chair","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Audit; Compensation · Chair committee of Cartesian Therapeutics, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cn4y3518w9qml","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:carrie-s-cox","alpha:committee:cartesian-therapeutics-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Carrie S. Cox member of Audit; Compensation · Chair, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1jhj0rj10trb6v","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:carsten-brunn-ph-d","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Carsten Brunn, Ph.D. seat on Cartesian Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:f6na5im4nurq","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:patrick-zenner-m-b-a","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Patrick Zenner, M.B.A. seat on Cartesian Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:q5o8dq1w7oq3s","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:timothy-a-springer-ph-d","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Timothy A. Springer, Ph.D. seat on Cartesian Therapeutics, Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wo0jnx1gh383x","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:52:54.339891+00:00","subject_ids":["alpha:person:timothy-c-barabe-m-b-a","alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7"],"caused_claim_ids":["alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a"],"summary":"Timothy C. Barabe, M.B.A. seat on Cartesian Therapeutics, Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:5","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:carrie-s-cox","object_label":"Carrie S. Cox","object_source_name_forms":[],"value":"Carrie S. Cox: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:carrie-s-cox","name":"Carrie S. Cox"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:6","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:carsten-brunn-ph-d","object_label":"Carsten Brunn, Ph.D.","object_source_name_forms":[],"value":"Carsten Brunn, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:carsten-brunn-ph-d","name":"Carsten Brunn, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:7","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kemal-malik-m-b-b-s","object_label":"Kemal Malik, M.B.B.S.","object_source_name_forms":[],"value":"Kemal Malik, M.B.B.S.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kemal-malik-m-b-b-s","name":"Kemal Malik, M.B.B.S."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:8","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-singer-m-d-ph-d","object_label":"Michael Singer, M.D., Ph.D.","object_source_name_forms":[],"value":"Michael Singer, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-singer-m-d-ph-d","name":"Michael Singer, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:9","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:murat-kalayoglu-m-d-ph-d","object_label":"Murat Kalayoglu, M.D., Ph.D.","object_source_name_forms":[],"value":"Murat Kalayoglu, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:murat-kalayoglu-m-d-ph-d","name":"Murat Kalayoglu, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:10","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nishan-de-silva-m-d-m-b-a","object_label":"Nishan de Silva, M.D., M.B.A.","object_source_name_forms":[],"value":"Nishan de Silva, M.D., M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nishan-de-silva-m-d-m-b-a","name":"Nishan de Silva, M.D., M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:11","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:patrick-zenner-m-b-a","object_label":"Patrick Zenner, M.B.A.","object_source_name_forms":[],"value":"Patrick Zenner, M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:patrick-zenner-m-b-a","name":"Patrick Zenner, M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:12","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:timothy-a-springer-ph-d","object_label":"Timothy A. Springer, Ph.D.","object_source_name_forms":[],"value":"Timothy A. Springer, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:timothy-a-springer-ph-d","name":"Timothy A. Springer, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:13","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:timothy-c-barabe-m-b-a","object_label":"Timothy C. Barabe, M.B.A.","object_source_name_forms":[],"value":"Timothy C. Barabe, M.B.A.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:timothy-c-barabe-m-b-a","name":"Timothy C. Barabe, M.B.A."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:14","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:chris-jewell-ph-d","object_label":"Chris Jewell, Ph.D.","object_source_name_forms":[],"value":"Chris Jewell, Ph.D.: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:chris-jewell-ph-d","name":"Chris Jewell, Ph.D."},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:d9c326fbc68efba709f97bcbe5eaa467259e9a0a435163bfaca28386c1f3ed51","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RNAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:43:15.714806+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b10b2d37-3139-4da4-b278-732e3f5292c7:leadership_role:15","subject_id":"alpha:company:b10b2d37-3139-4da4-b278-732e3f5292c7","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:metin-kurtoglu-m-d-ph-d","object_label":"Metin Kurtoglu, M.D., Ph.D.","object_source_name_forms":[],"value":"Metin Kurtoglu, M.D., Ph.D.: Chief Technology Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:metin-kurtoglu-m-d-ph-d","name":"Metin Kurtoglu, M.D., Ph.D."},"title":"Chief Technology Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-16T13:52:54.339891+00:00","sources":[{"id":"alpha:projection-evidence:document:119a80c5445b9498e6e4a1eef46f92b9a98732202336688ad2930bff031afba8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RNAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:43:15.113033+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:c54196686ba2cfd518e973089f9164656fcde36d5f3a9b16e6393cfe7c12d20a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cartesian Therapeutics, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000075/rnac-20250428.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:41:01.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d9c326fbc68efba709f97bcbe5eaa467259e9a0a435163bfaca28386c1f3ed51","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RNAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:43:15.714806+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:119a80c5445b9498e6e4a1eef46f92b9a98732202336688ad2930bff031afba8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RNAC 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:43:15.113033+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.847,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.863,"cross_source_agreement":0.75,"temporal_completeness":0.846},"diagnostics":{"published_claims":19,"factual_claims":19,"claims_with_linked_evidence":19,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":13,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:52:54.339891+00:00","observed_at":"2026-10-16T13:52:54.339891+00:00","reviewed_at":"2026-10-16T13:52:54.339891+00:00","verified_at":"2026-10-16T13:52:54.339891+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/cartesian-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/cartesian-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}